Related Experiment Video
Updated: Jun 12, 2026
07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
3-Formylchromones: potential antiinflammatory agents.
Khalid M Khan1, Nida Ambreen, Uzma Rasool Mughal
1H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan. hassaan2@super.net.pk
European Journal of Medicinal Chemistry
|June 26, 2010
Summary
Researchers synthesized novel 3-formylchromone derivatives and evaluated their anti-inflammatory potential. Several compounds demonstrated significant anti-inflammatory effects in both in vitro and in vivo models, comparable to standard drugs.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Inflammation is a complex biological response implicated in numerous diseases.
- Chromone derivatives are known for diverse pharmacological activities.
- Development of novel anti-inflammatory agents is crucial for therapeutic advancements.
Purpose of the Study:
- To synthesize and characterize a series of 3-formylchromone derivatives.
- To evaluate the in vitro and in vivo anti-inflammatory activities of these novel compounds.
- To compare the efficacy of synthesized compounds with established anti-inflammatory drugs like aspirin and indomethacin.
Main Methods:
- Synthesis of 3-formylchromone derivatives (compounds 1-24).
- Characterization using spectroscopic techniques: (1)H NMR, EI MS, IR, UV, and elemental analysis.
- Evaluation of anti-inflammatory activity through various in vitro and in vivo assay models.
Main Results:
- Successful synthesis and full characterization of 24 novel 3-formylchromone derivatives.
- Compounds 1, 2, 5, 6, 9, 14, 16-19, and 21-23 exhibited significant anti-inflammatory activities.
- Structure-activity relationships (SAR) were analyzed and discussed based on the observed activities.
Conclusions:
- The synthesized 3-formylchromone derivatives represent a promising class of compounds for anti-inflammatory drug development.
- Specific derivatives demonstrated potent anti-inflammatory effects, warranting further investigation.
- The study provides valuable insights into the SAR of 3-formylchromone derivatives for anti-inflammatory applications.
Related Concept Videos
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...